MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -676.85% | -503.96% | -5.69% | 115.15% | 123.06% |
| Total Depreciation and Amortization | -30.30% | -28.82% | -33.85% | -35.79% | -33.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.14% | 136.38% | 102.22% | -431.41% | -267.43% |
| Change in Net Operating Assets | 139.28% | 152.86% | -194.16% | -147.00% | -129.71% |
| Cash from Operations | -1,159.08% | -826.50% | -2,208.57% | -295,700.00% | 39.39% |
| Capital Expenditure | 125.00% | 50.00% | 25.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -99.09% | 1,818.18% | 1,818.18% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -99.01% | -100.92% | -100.46% | 1,754.55% | 1,745.45% |
| Total Debt Issued | 16.11% | 21.11% | 14.81% | 13.48% | 9.49% |
| Total Debt Repaid | 6.83% | -6.88% | -2.02% | -8.45% | -11.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,561.25% | 547.99% | 643.78% | 2,335.24% | -53.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.08% | -265.61% | -53.06% | -269.83% | -620.00% |
